Back to search

Democritus University of Thrace (DUTH)

Συγκριτική μελέτη σχημάτων κλασματοποίησης της ακτινοθεραπείας στον καρκίνο της ουροδόχου κύστης

Abstract

dc:description

Introduction: Radiotherapy (RT) for bladder cancer is as an effective alternative of cystectomy. Although rapid cancer clonogen repopulation contributes to radio-resistance, accelerated radiotherapy schemes based on ?2Gy fractions have failed to improve results. We suggest that accelerated hypofractionation (HypoARC) may be more effective, as it targets both tumors with increased clonogenic activity and tumors with low radio-sensitivity. Patients and Methods: Eighty-two bladder cancer patents were treated with concomitant-boost conformal radiotherapy (14x2.7Gy to the pelvis and 15x3.4Gy to the bladder, within 19 days). Patients received a daily dose of 0/500/750/1000mg of amifostine using a dose-individualization algorithm (15.8%, 8.5%, 19.5% and 56.1% of patients respectively). Liposomal doxorubicin (Caelyx®) 20mg/m2 every two weeks was administered in 41/82 patients, for a total of 3-6 cycles (median 3). The median follow-up of patients alive at the time of analysis ranges from 2-61 months (median 19 months). An additional control cohort of 84 patients with bladder cancer, treated with standard fractionation was also retrospectively analyzed for the acute and late radiation toxicities and the tumor response rates. The median follow-up of these patients is 22 months (range 2-79 months). Results: Using the dose individualization algorithm, 46/82 (56.1%) patents received a daily dose of 1000mg of amifostine, 16/82 (19.5%) 750mg and 7/82 (8.5%) 500mg. 13/82 (15.8%) patients interrupted amifostine due to intolerable nausea and/or fatigue noted at 500mg that did not ameliorate with dexamethasone. Patients receiving HypoARC had significantly less frequency grade 2-3 (10.9% vs. 25%, p=0.006), and less dysurea grade 1-2 (15.8% vs. 59.5%, p=0.0001). Bladder infection was similar in both groups (3.7% vs. 4.8%, p=0.72). Out of 82 patients of the HypoARC group, 8.5% developed grade 2 and 22% grade 1 diarrhoea. This incidence was significantly lower compared to the (22.6% and 41.7% rates in the standard RT group (p=0.0001). Proctitis grade 1-2 appeared in 39% of patients who underwent hypoARC and in 53.6% of them treated with standard RT. The difference did not reach significance (p=0.12). Severe grade 3 proctitis appeared in 1.2% and 2.4% of patients in the two groups, respectively. Skin / perineal toxicity was very low in both groups.Within a median follow-up of 19 months (2-61 months) patients treated with HypoARC showed a low incidence of severe late sequel. Patients treated with HypoARC had a very low incidence of late sequel. There was 1 (1.2%) case with frequency grade 2, 2 (2.4%) cases with grade 2-3 dysurea, 2 (2.4%) cases with grade 2-3 ematurea, and 2 (2.4%) cases with bladder incontinence grade 2-3. Comparison with the standard radiotherapy regimen showed a significant reduction of frequency in the HypoARC group (p=0.001). Following HypoARC the complete response rate was 86.6%. This was higher in the T1 stage (100%) and dropped gradually to 90.9% in the the T2 stage and to 79.5% in the T3,4 stage. There was no, however, a statistically significant difference (p>0.18). ..........................................................

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2010

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Panteliadou, Marianthi
  • Παντελιάδου, Μαριάνθη

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/21779

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Panteliadou, Marianthi; Παντελιάδου, Μαριάνθη. Συγκριτική μελέτη σχημάτων κλασματοποίησης της ακτινοθεραπείας στον καρκίνο της ουροδόχου κύστης. Democritus University of Thrace (DUTH), 2010. http://hdl.handle.net/10442/hedi/21779